|
Nephrology and Hypertension Journal Club Hexasodium fytate for the treatment of calciphylaxis a randomised double blind phase 3 placebo controlled trial with an open label extention May 23 2025 |
05/23/2025 - 7:30am to 8:30am |
|
Nephrology and Hypertension Journal Club Intravenous Magnesium and Cisplatin Associated Acute Kidney Injury June 13 2025 |
06/13/2025 - 7:30am to 8:30am |
|
Nephrology and Hypertension Journal Club Intravenous Magnesium and Cisplatin Associated Acute Kidney Injury June 13 2025 |
06/20/2025 - 7:30am to 8:30am |
|
Nephrology and Hypertension Journal Club Intravenous Magnesium and Cisplatin Associated Acute Kidney Injury June 13 2025 |
06/27/2025 - 7:30am to 8:30am |
|
Nephrology and Hypertension Journal Club Expanded Hemodialysis with Theranova Dialyzer and Residual Kidney Function in Patients Starting Long Term Hemodialysis July 11 2025 |
07/11/2025 - 7:30am to 8:30am |
|
Nephrology and Hypertension Journal Club Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension July 18 2025 |
07/18/2025 - 7:30am to 8:30am |
|
Nephrology and Hypertension Journal Club Add On Treatment With Zilebesiran for Inadequately Controlled Hypertension The KARDIA 2 Randomized Clinical Trial August 1 2025 |
08/01/2025 - 7:30am to 8:30am |
|
Nephrology and Hypertension Journal Club Enhancement of angiotensin II type 1 receptor0associated protein suppresses kidney inflammation in a mouse model of aristolochic acid nephropathy August 15, 2025 |
08/15/2025 - 7:30am to 8:30am |
|
Nephrology and Hypertension Journal Club Osteoporosis Management in CKD and ESKD August 29 2025 |
08/29/2025 - 7:30am to 8:30am |
|
Nephrology and Hypertension Journal Club Spironolactone versus placebo in patients undergoing maintenance dialysis ACHIEVE an international parallel group randomised controlled trial |
09/05/2025 - 7:30am to 8:30am |
Facebook
X
LinkedIn
Forward